Abstract
Metabolic studies using radioiodine-labeled third component of complement (C3) and the glycine-rich beta glycoprotein (GBG), a major component of the C3b-feedback pathway, were undertaken in normal subjects, in 22 patients with evidence of complement activation, and in 11 patients with various renal diseases without evidence of complement activation. In seven normal subjects GBG was found to be a rapidly metabolized protein with catabolic rates ranging from 1.7% to 2.2% of the plasma pool/h, synthesis rates from 0.14 to 0.21 mg/kg per h. and extravascular/intravascular distribution ratios from 0.81 to 1.31. In patients with reduced plasma C3, both increased C3 fractional catabolic rates and reduced C3 synthesis rates were observed, and in some patients there was evidence of increased extravascular distribution of the protein. GBG catabolism was usually increased when there was evidence of C3 activation, presumably reflecting activation of the C3b-feedback; but GBG turnover was normal or only slightly accelerated in some patients with accelerated C3 catabolism and profound hypocomplementemia, suggesting that reduced C3 synthesis had limited activation of the C3b-feedback.
MeSH Terms
Complement Inactivator Proteins
Complement System Proteins/biosynthesis,isolation & purification
Erythrocytes/metabolism
Feedback
Glycine/metabolism
Glycoproteins/blood,metabolism
Humans
Immunologic Deficiency Syndromes/blood,metabolism
Iodine Radioisotopes
Kidney Diseases/metabolism
Metabolic Clearance Rate
Properdin/analysis
Protein Binding
Chemicals
Complement Inactivator Proteins
Glycoproteins
Iodine Radioisotopes
Properdin
Complement System Proteins
Glycine
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Charlesworth J A
Williams D G
Sherington E
Lachmann P J
Peters D K
References (27)
27 references, click to expand
-
Complement studies in membrano-proliferative glomerulonephritis.
Clin Exp Immunol. 1972 Jul;11(3):311-20
PMID: 4625395
-
A method of trace iodination of proteins for immunologic studies.
Int Arch Allergy Appl Immunol. 1966;29(2):185-9
PMID: 4160044
-
Metabolism of the third component of complement (C3) in normal human subjects.
Clin Sci Mol Med. 1974 Feb;46(2):223-9
PMID: 4817274
-
Hypocomplementemia with cutaneous vasculitis and arthritis. Possible immune complex syndrome.
Mayo Clin Proc. 1973 May;48(5):340-8
PMID: 4267356
-
Properdin anc C3 proactivator: alternate pathway components in human glomerulonephritis.
J Clin Invest. 1973 Mar;52(3):634-44
PMID: 4630981
-
The theory of tracer experiments with 131I-labelled plasma proteins.
Phys Med Biol. 1957 Jul;2(1):36-53
PMID: 13484460
-
Isolation and properties of a glycine-rich beta-glycoprotein of human serum.
Biochim Biophys Acta. 1970 Dec 22;221(3):529-35
PMID: 5499437
-
The alternate pathway of complement activation. The role of C3 and its inactivator (KAF).
Immunology. 1973 Feb;24(2):259-75
PMID: 4632688
-
Distribution and metabolism of I131 labeled proteins in man.
Fed Proc. 1957 Jul;16(2):suppl 13-8
PMID: 13461943
-
Serum C'3 lytic system in patients with glomerulonephritis.
Science. 1969 Apr 25;164(3878):436-7
PMID: 4180576
-
Metabolism of third complement component (C3) in nephritis. Involvement of the classic and alternate (properdin) pathways for complement activation.
N Engl J Med. 1972 Oct 26;287(17):835-40
PMID: 4627271
-
Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection.
J Clin Invest. 1970 Nov;49(11):1975-85
PMID: 4097977
-
Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients.
J Clin Invest. 1967 Dec;46(12):2021-34
PMID: 6074005
-
C3 inactivating factor in the serum of a patient with chronic hypocomplementaemic proliferative glomerulo-nephritis.
Immunology. 1972 Jan;22(1):147-58
PMID: 4622449
-
Metabolism of radio-labelled C3: effects of in vivo activation in rabbits.
Clin Exp Immunol. 1974 Mar;16(3):445-52
PMID: 4468849
-
Mesangiocapillary nephritis, partial lipodystrophy, and hypocomplementaemia.
Lancet. 1973 Sep 8;2(7828):535-8
PMID: 4125297
-
Chronic glomerulonephritis associated with low serum complement activity (chronic hypocomplementemic glomerulonephritis).
Medicine (Baltimore). 1970 May;49(3):207-26
PMID: 4910985
-
ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS.
Anal Biochem. 1965 Feb;10:358-61
PMID: 14302464
-
Increased susceptibility to infection in a patient with type II essential hypercatabolism of C3.
N Engl J Med. 1973 Mar 22;288(12):601-6
PMID: 4686987
-
Analysis of disappearance time-curves after single injection of labelled proteins.
Ciba Found Symp. 1972;9:113-30
PMID: 4573089
-
The purification of specific antibody as F(ab')2 by the pepsin digestion of antigen-antibody precipitates, and its application to immunoglobulin and complement antigens.
Immunochemistry. 1971 Jan;8(1):81-8
PMID: 4100767
-
The relationship of glycine-rich -glycoprotein to factor B in the properdin system and to the cobra factor-binding protein of huan serum.
J Exp Med. 1973 Feb 1;137(2):424-37
PMID: 4734403
-
C3 proactivator convertase and its mode of action.
J Exp Med. 1972 Apr 1;135(4):1003-8
PMID: 4111773
-
Decreased synthesis of the third component of complement (C3) in hypocomplementemic systemic lupus erythematosus.
Clin Exp Immunol. 1972 May;11(1):21-9
PMID: 5038771
-
Inactivator of the third component of complement as an inhibitor in the properdin pathway.
Proc Natl Acad Sci U S A. 1972 Oct;69(10):2910-3
PMID: 4507613
-
Glomerular deposition of properdin in acute and chronic glomerulonephritis with hypocomplementemia.
J Clin Invest. 1971 Mar;50(3):642-9
PMID: 5545124
-
Role of C3b in the breakdown of C3 in hypocomplementaemic mesangiocapillary glomerulonephritis.
Lancet. 1973 Mar 3;1(7801):447-9
PMID: 4120364